Structural Heart
November 9, 2026
Can TAVR Make PROGRESS Against Moderate AS? November 9, 2026
To TAVR or not to TAVR, that is the question central to the PROGRESS trial presented at TCT 2026, and its results suggest the answer might be the former for certain high-risk patients with moderate AS.
Cardiac Imaging
November 6, 2026
In My Practice: Using Cardiac CT to Keep Athletes in the Game November 6, 2026
Every week, my clinic sees very different kinds of hearts under the same word: "athlete."
Cardiology
November 4, 2026
The Top Trends of TCT 2026 November 4, 2026
This year marked the 38th TCT 2026 conference, back on Cardiac Wire’s home turf in San Diego for only the second time. As the name implies catheter-based heart therapies are still the core of the meeting, but this year’s late-breakers and booth conversations showed just how much this cutting-edge cardiac segment is maturing.